IGEM:Harvard/2006/DNA nanostructures/Notebook/2006-8-14

Goals for today

Microcon Purification Tweaking

• repeat Friday's mega PEG ppt on 5.0 (?)
• Micron experiments with 0.1% and 0.01% SDS in buffer
  • ...and use 1x folding buffer and not water for washes
  • also: perform control expt with 10 bp+ ladder, since according to Millipore documentation, the filter should retain ds DNAs longer than 100 bp

Streptavidin-Bead "Protection" Assay on Inside- and Outside-Biotinylated c5.0

• NB: no good purification of nanostructure from oligo has been achieved, but gel separation after elution should differentiate formerly bead-bound oligos from formerly bead-bound nanostructures

Redux of [Mg++], [oligos]

• Based on the inconclusive gels from last Monday, the titration will be redone with c5.0 at 8% PEG, 0.5M NaCl final.

Mg2+, Oligo-Concentration Titration w/ c5.0

Goals

• vary folding conditions ([MgCl₂] and [oligo]) in order to determine best folding conditions for c5.0
• determine most efficient purification protocol (Microcon vs. PEG) based on recovery yields

Protocol

1. Working Stock Concentration

• concentrated 6 tubes of 96 μL c5.0D.L (no latches, outside-bound ligand) in Vacufuge so that [oligo]= 250nM * 6 = 1.5 μM

2. Folding Rxns

• used three different folding buffers varying [MgCl₂]
• used two different [oligo concentrations]: 250 nM from the unconcentrated working stock, 1.5 μM from above
• folding conditions: 80[[:Category:{{{1}}}|{{{1}}}]] for 2 min., decrease 1[[:Category:{{{1}}}|{{{1}}}]] every 2 min. for 59 more times

Trial	Oligos	p7308 (44 nM)	Folding Buffer (10x)	Water
1a,b	16 μL 250 nM	9 μL	4 μL 100 mM MgCl2	11 μL
2a,b	16 μL 1.5 μM	9 μL	4 μL 100 mM MgCl2	11 μL
3a,b	16 μL 250 nM	9 μL	4 μL 200 mM MgCl2	11 μL
4a,b	16 μL 1.5 μM	9 μL	4 μL 200 mM MgCl2	11 μL
5a,b	16 μL 250 nM	9 μL	4 μL 300 mM MgCl2	11 μL
6a,b	16 μL 1.5 μM	9 μL	4 μL 300 mM MgCl2	11 μL

1

Microcon w/ detergent

• add 20 μL given nanostructure to center of YM-50 Micrcon tube
• add 480 μL given folding buffer, microcentrifuge for 6 min. at 14k rcf, and repeat dilution and spinning 4 more times
• yielded approx. 100 μL retentate, which was concentrated to 15 to 60 μL in a Vacufuge (about 30 min. at 45 [[:Category:{{{1}}}|{{{1}}}]]), depending on the sample

lane	starting amt. of nanostructures	wash buffer	loaded onto gel
1			7 μL 1 kb+ ladder
2			2.25 μL p7308
3			10 μL unpurified 4.0.I
4	20 μL 6hb	1x folding buffer (10 mM MgCl2)	half of retentate
5	20 μL 6hb	1x folding buffer (10 mM MgCl2) w/ 0.1% SDS	half of retentate
6	20 μL 4.0.I	1x folding buffer (10 mM MgCl2)	half of retentate
7	20 μL 4.0.I	1x folding buffer (10 mM MgCl2) w/ 0.01% SDS	half of retentate
8	20 μL 4.0.I	1x folding buffer (10 mM MgCl2) w/ 0.1% SDS	half of retentate

• ran 2% agarose gel at 80 V for 1 h. Gel appears to be of such low qualitiy that the results are inconclusive (ladder isn't clear)
• ran another 2% agarose gel at 60V for 1 h.
• results/discussion
  • unclear why 6hb filtration failed (oligos were retained) (lane 4)
  • 0.1% SDS gives unusual/unknown smears (lanes 5 and 8)
    • under visible light, there are thin pink-red bands in the middle of these smears. is SDS breaking down the Microcon tube plastic?
  • 0.01% SDS possibly gives higher yields than no SDS (lane 7 vs. lane 6), but it is not conclusively better yield, and it is still very poor overall yield (lane 7 vs. lane 3)

Streptavidin Bead "Protection"

• Issues:
  • No protocol found for the Fluka agarose streptavidin beads, and the NEB magnetic bead protocol's heating requirements seem unsuitable for keeping nanoboxes folded throughout the process
    • Nanoboxes must remain folded post-elution because they must be gel-distinguishable from eluted biotinylated oligos, which we have not been able to pre-purify out by other means.

• • Elution methods are of two types:
  • 1. Overload with competitors - either streptavidin or biotinylated oligos
    • But can't: biotin-streptavidin bond is so strong that dissociation by competition would theoretically take years
  • 2. Denature the streptavidin using a) formamide, b) phenol, c) SDS + boiling
    • But can't: all the conditions require heat that might damage the nanostructures (65%degC and up)

• Solution:
  • Degrade streptavidin with trypsin
    • Trypsin must be in solution w/o EDTA, which would otherwise chelate all the Mg2+ in the DNA nanobox solution that is necessary to keeping it folded.

• Protocol:

1. Incubate:
     5uL beads (binding capacity: 2pmol/1uL, thus, 10pmol - far greater than the available binding sites in the DNA nanobox solutions)
     35uL 1x folding buffer
     10uL test solution

           TEST SOLUTIONS:
           --------------
           a) H2O (ie. test = no biotin in solution)
           b) biotinylated oligos (c5.0.8(b)) - 250uM per oligo in pre-working stock = 1mM biotinylation - for 1.6pmol = 1.6uL - thus, 1.6uL + 8.4uL H2O must be added for test solution
           c) c5.0 E(b) (outside biotinylation) (was Microcon "purified" Tu 8.9) - ~2000fmol of binding sites/12.5uL, or 0.16pmol/ul - thus, 1.6pmol 
           d) c5.0 F(b) (inside biotinylation) (was Microcon "purified" Tu 8.9) - "

2. Vortex
3. Pellet by drawing magnet down to bottom of tube.
4. Discard supernatant
5. Add 100uL 1x folding buffer

6. Repeat steps 2-5 three more times.

7. Trypsinize by adding to pellet:
      3uL trypsin (1mg/mL)
      27uL 1x folding buffer
8. Incubate 4hr-overnight @ 37 degrees C

9. Pellet by drawing magnet down to bottom of tube and remove supernatant to clean tube.
10. Run 20uL of each supernatant on 2% agarose gel (10mM MgCl2) for 1hr at 80V.